3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application
Open Access
- 20 January 2020
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-14
Abstract
Background: The aim of this retrospective study was to compare the feasibility and efficiency of ultrasound-guided percutaneous microwave ablation (US-PMWA) assisted by three-dimensional visualization ablation planning system (3DVAPS) and conventional 2D planning for hepatocellular carcinoma (HCC) (diameter > 3 cm). Methods: One hundred thirty patients with 223 HCC nodules (5.0 ± 1.5 cm in diameter, [3.0–10.0 cm]) who met the eligibility criteria divided into 3D and 2D planning group were reviewed from April 2015 to August 2018. Ablation parameters and oncological outcomes were compared, including overall survival (OS), recurrence-free survival (RFS), and local tumor progression (LTP). Multivariate analysis was performed on clinicopathological variables to identify the risk factors for OS and LTP. Results: The median follow-up period was 21 months (range 3–44). Insertion number (5.4 ± 1.2 VS. 4.5 ± 0.9, P = 0.034), ablation time (1249.2 ± 654.2 s VS. 1082.4 ± 584.7 s, P = 0.048), ablation energy (57,000 ± 11,892 J VS. 42,600 ± 10,271 J, P = 0.038) and success rate of first ablation (95.0% VS. 85.7%, P = 0.033) were higher in the 3D planning group compared with those in 2D planning group. There was no statistical difference in OS, and RFS between the two groups (P = 0.995, P = 0.845). LTP rate of 3D planning group was less than that of 2D planning group (16.5% VS 41.2%, P = 0.003). Multivariate analysis showed tumor maximal diameters (P < 0.001), tumor number (P = 0.003) and preoperative TACE (P < 0.001) were predictors for OS and sessions (P = 0.024), a-fetoprotein level (P = 0.004), and preoperative planning (P = 0.002) were predictors for LTP, respectively. Conclusions: 3DVAPS improves precision of US guided ablation resulting in lower LTP and higher 5 mm-AM for patients with HCC lesions larger than 3 cm in diameter.Keywords
Funding Information
- The National Key R&D Program of China (2017YFC0112000)
- The National Scientific Foundation Committee of China (81627803, 91859201, 81871374)
- Clinical Research Support Foundation of the Chinese PLA General Hospital. (2017FC-CXYY-3005)
- State Key Project on Infectious Disease of China (2018ZX10723204)
This publication has 33 references indexed in Scilit:
- Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular CarcinomaJAMA Surgery, 2019
- Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective StudyJournal of Clinical and Translational Hepatology, 2018
- Application of three-dimensional visualization technique in preoperative planning of progressive hilar cholangiocarcinoma2018
- Use of microwave ablation in the treatment of patients with multiple primary malignant tumorsThoracic Cancer, 2017
- CT-guided microwave ablation through the lungs for treating liver tumors near the diaphragmOncotarget, 2017
- Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditionsMedical Oncology, 2017
- Repeated Radiofrequency Ablation Combined With Ablated Lesion Elimination and Transarterial Chemoembolization Improves the Outcome of Solitary Huge Hepatocellular Carcinomas 10 cm or LargerMedicine, 2016
- High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrenceClinical Radiology, 2015
- Microwave Ablation for Hepatic MalignanciesAnnals of Surgery, 2014
- A three-dimensional visualisation preoperative treatment planning system in microwave ablation for liver cancer: A preliminary clinical applicationInternational Journal of Hyperthermia, 2013